The Form 4 filing for ISRG was filed on October 26, 2026. This report of insider share activity covers a trade dated October 23, 2026.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-23 |
| Date of Latest Transaction | 2026-10-23 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 1,150 |
| Price | $443.80 |
| Total Transaction Value | $510,370.00 |
| Insider | |
| Ticker Symbol | ISRG |
| Company | INTUITIVE SURGICAL INC |
| Insider Name | BARRATT CRAIG H |
| Insider Title | Director |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 0 |
| Position Size Change | 100.00% |
| Filing | |
| Filing Date | 2026-10-26 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share sale under transaction code S. The available details also suggest a related exercise or conversion, as explained below.
What was the average price of the transaction?
The average sale price was $443.80 per share.
How did this transaction affect the insider's holdings?
Craig H. Barratt sold 1,150 shares, or 100.00% of the shares in the reported balance before the sale. That balance was zero shares afterward. Any holdings outside that balance are unknown.
What's the total transaction value?
The single reported sale had a total value of $510,370.00.
Are there any special circumstances around this transaction?
Yes. The transaction information includes a Rule 10b5-1 plan reference. These plans set trading instructions in advance. The reference alone does not establish whether the plan covers this specific sale.
Matching share counts also suggest a link to an exercise or conversion under code M. An exercise uses an existing right to get shares. A conversion exchanges another holding for shares.
The related code M entry and filing footnotes are unavailable. The link does not confirm that these were the same shares or that both steps happened on the same day. It also does not establish that the sale paid taxes or was required.
For research purposes only; not investment advice.